PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Usl Umbria 1, Perugia, Italy. francesco.ferrara@uslumbria1.it.\', \'Asl Salerno, Salerno, Italy.\', \'Usl Umbria 2, Terni, Italy.\', \'Asur Marche, Ancona, Italy.\', \'Usl Umbria 1, Perugia, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s00228-020-02947-4
?:doi
?:hasPublicationType
?:journal
  • European journal of clinical pharmacology
is ?:pmid of
?:pmid
?:pmid
  • 32594204
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.159
?:rankingScore_hIndex
  • 96
is ?:relation_isRelatedTo_publication of
?:title
  • The added value of pirfenidone to fight inflammation and fibrotic state induced by SARS-CoV-2 : Anti-inflammatory and anti-fibrotic therapy could solve the lung complications of the infection?
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32594204>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32594204>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all